Christina Christersson

Author

Also Known As

Alaide Chieffo, C C Christersson, C Christersson, C. CHRISTERSSON, C. Christersson, Catrin Henriksson, Christina Christersson, E Furenäs, F Marchi, Gill Louise Buchanan

162

Publications

6.7K

Citations

H-Index

Concepts

All Affiliations

Uppsala University Lund University Umeå University University of Gothenburg Karolinska Institutet

About

Christina Christersson is an author at Uppsala University specializing in medicine, cardiology, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	22	1.4K
2	Public Health	7	7	432
3	Health Sciences	3	3	82
4	Engineering	1	1	423
5	Allergy	1	1	22

Christina Christersson

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
A Randomized Trial of Genotype-Guided Dosing of Warfarin Munir Pirmohamed, Girvan Burnside, Niclas Eriksson, New England Journal of Medicine	2013	802
Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study David Erlinge, Akiko Maehara, Ori Ben‐Yehuda, The Lancet Medical UltrasoundEngineeringVascular ImageMedical ImagingMedicine	2021	423
N-Terminal Pro–B-Type Natriuretic Peptide for Risk Assessment in Patients With Atrial Fibrillation Ziad Hijazi, Lars Wallentin, Agneta Siegbahn, Journal of the American College of Cardiology Risk AssessmentCardiovascular DiseasePharmacologyCardiovascular PharmacologyPharmacotherapy	2013	226
Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial Hiddo J.L. Heerspink, C. David Sjöström, Niels Jongs, European Heart Journal	2021	118
D‐dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation – observations from the ARISTOTLE trial Christina Christersson, Lars Wallentin, Ulrika Andersson, Journal of Thrombosis and Haemostasis ThrombosisVenous ThrombosisAristotle TrialCardiovascular DiseaseFibrinolysis	2014	99
A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function Hiddo J.L. Heerspink, David Z.I. Cherney, Douwe Postmus, Kidney International	2021	92
Compared with matched controls, patients with postoperative atrial fibrillation (POAF) have increased long-term AF after CABG, and POAF is further associated with increased ischemic stroke, heart failure and mortality even after adjustment for AF Emma Thorén, Mona-Lisa Wernroth, Christina Christersson, Clinical Research in Cardiology	2020	90
Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide study Hyeon‐Jong Yang, Berto J. Bouma, Konstantinos Dimopoulos, International Journal of Cardiology ThrombosisWorldwide StudyCardiovascular DiseasePharmacologyCardiology	2019	80
High incidence of infective endocarditis in adults with congenital ventricular septal defect Elisabeth Berglund, Bengt Johansson, Mikael Dellborg, Heart	2016	68
Pregnancy Complications and Risk of Cardiovascular Disease Later in Life: A Nationwide Cohort Study Elin Täufer Cederlöf, Maria Lundgren, Bertil Lindahl, Journal of the American Heart Association HypertensionPregnancy DisordersGynecologyCardiovascular Disease LaterHigh-risk Pregnancy	2022	67

Page 1